DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20180102

Status of package insert guidelines for drugs accessible as over the counter drugs

Anuja Jha, Usha Joshi, Rajesh Hishikar, Manju Agrawal, Ajay Halwai

Abstract


Background: As per Indian pharmacopoeia, package inserts are part of a label that provides information on the article. It may be the sole source of information for drugs, which are available in the pharmacies without the prescription and it may include both prescription and over the counter (OTC) drugs. So, to aid in safety and efficacy of these drugs, package inserts must follow the standard guidelines (The Drugs and Cosmetics rule, 1945). The objective of this study was to observe the status of the standard guidelines for package insert in drugs accessible as OTC drugs.

Methods: Based on the inquiries made with pharmacies, list of drugs commonly bought without prescription was made. 256 drugs were evaluated. Their package inserts were observed for the extent to which the guidelines given by The Drugs and Cosmetics rule 1945, section 6.2 and 6.3 are being followed. Secondary objectives were made to assess if package inserts are physician friendly or patients friendly.

Results: Package inserts were missing in 180 (70%) of the drugs.  Therapeutic indications were present in 71% of the available package inserts (76). Pharmaceutical information was given in 57% of the package inserts. English was the preferred language and medicinal terms were used. Only one package insert was patient friendly.

Conclusions: Package inserts should be made available in every drug. There should be a separate patient oriented package insert guideline, as per US food and drug administration (FDA), in India as well. This will aid in their safe and effective use.


Keywords


Drugs and cosmetics Rule, Over the counter drug (OTC), Package insert

Full Text:

PDF

References


Parikh D, Sattigeri BM, Kumar A, Brahmbhatt S. A survey study on use of over the counter (OTC) drugs among medical students, nursing and clerical staff of a tertiary care teaching rural hospital. Int J Res Med Sci. 2017;1(2):83-6.

Hsämeen-Anttila K, Nordeng H, Kokki E, Jyrkkä J, Lupattelli A, Vainio K, et al. Multiple information sources and consequences of conflicting information about medicine use during pregnancy: a multinational Internet-based survey. J Med Int Res. 2014;16(2).

Diaz JA, Griffith RA, Ng JJ, Reinert SE, Friedmann PD, Moulton AW. Patients' use of the Internet for medical information. J General Internal Med. 2002;17(3):180-5.

Dass AS, Sarala N, Bhuvana K. Analysis of Package Inserts of Drugs Utilized in a Tertiary Care Hospital. J Young Pharmacists. 2016;8(3):275-8.

Indian Pharmacopoeia 2007. Available at: http://ajprd.com/downloadebooks_pdf/9.pdf. Accessed 25 December 2017.

Food and drug administration. An Introduction to the Improved FDA Prescription Drug Labeling. Available at: https://www.fda.gov/downloads/training/forhealthprofessionals/ucm090796.pdf. Accessed 24 November 2017.

Central Drugs Standard Control Organization. The drugs and cosmetics act and rules. Available at: http://www.cdsco.nic.in/writereaddata/2016Drugs%20and%20Cosmetics%20Act%201940%20and%20Rules%201945.pdf. Accessed 25 November 2017.

Food and drug administration. Drug Applications for Over-the-Counter (OTC) Drugs. Available at: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/Over-the-CounterDrugs/default.htm. Accessed 24 November 2017.

Menon SJ. Psychotropic medication during pregnancy and lactation. Arch Gynecol Obstet. 2008;277(1):1-3.

Cantrell L, Suchard JR, Wu A, Gerona RR. Stability of active ingredients in long-expired prescription medications. Arch Int Med. 2012;172(21):1685-7.

Gibbs S, Waters WE, George CF. Prescription information leaflets: a national survey. J Royal Soci Med. 1990;83(5):292-7.

Gibbs SH, Waters WE, George CF. The benefits of prescription information leaflets (2). Br J Clin Pharmacol. 1989;28(3):345-51.

Bansal V, Dhamija P, Medhi B, Pandhi P. Package inserts-do they have any role. JK-Practitioner. 2006;13(3):152-4.

Cunningham MR. Revolutionizing the Patient Package Insert with Infographics. BU Well. 2016;1(1):5.

Davis JE. Are one or two dangerous? Methyl salicylate exposure in toddlers. J Emerg Med. 2007;32(1):63-9.

Panda A, Pradhan S, Mohapatra G, Mohapatra J. Drug-related problems associated with self-medication and medication guided by prescription: A pharmacy-based survey. Indian J Pharmacol. 2016;48(5):515.

Malcolm R, Miller WC. Dimenhydrinate (Dramamine) abuse: hallucinogenic experiences with a proprietary antihistamine. Am J Psychiat. 1972;128(8):1012-3.

Serrano-Falcon B, Rey E. The safety of available treatments for chronic constipation. Expert Opinion on Drug Safety. 2017;16(11):1243-53.